These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 12184312)
1. New type of defibrillator. FDA Consum; 2002; 36(4):7. PubMed ID: 12184312 [No Abstract] [Full Text] [Related]
2. Post-market approval surveillance: a call for a more integrated and comprehensive approach. Mehran R; Leon MB; Feigal DA; Jefferys D; Simons M; Chronos N; Fogarty TJ; Kuntz RE; Baim DS; Kaplan AV Circulation; 2004 Jun; 109(25):3073-7. PubMed ID: 15226222 [No Abstract] [Full Text] [Related]
3. Medical-device safety and the FDA. Schultz DG N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278 [No Abstract] [Full Text] [Related]
4. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework? Basile EM; Lorell BH Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031 [No Abstract] [Full Text] [Related]
5. Semper fidelis--consumer protection for patients with implanted medical devices. Maisel WH N Engl J Med; 2008 Mar; 358(10):985-7. PubMed ID: 18322280 [No Abstract] [Full Text] [Related]
6. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective. Sapirstein W Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379 [No Abstract] [Full Text] [Related]
8. A surgeon's perspective of medical device regulation. Brantigan JW J Spinal Disord; 1995 Oct; 8(5):396-412. PubMed ID: 8563159 [No Abstract] [Full Text] [Related]
9. The Food and Drug Administration and atrial defibrillation devices. Chen L; Keane AT; Every NR Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410 [TBL] [Abstract][Full Text] [Related]
10. Not enough warning. GAO report finds FDA's medical device monitoring lacking. Hensley S Mod Healthc; 1997 Mar; 27(10):102, 104. PubMed ID: 10165267 [No Abstract] [Full Text] [Related]
11. The controversy over Guidant's implantable defibrillators. Steinbrook R N Engl J Med; 2005 Jul; 353(3):221-4. PubMed ID: 16034006 [No Abstract] [Full Text] [Related]
13. Devices and the food and drug administration. Phillips SJ; Phillips RS Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210 [No Abstract] [Full Text] [Related]
14. Evidence-based medicine and drug-eluting stents. O'Dwyer J Med Device Technol; 2004 May; 15(4):34-7. PubMed ID: 15303564 [TBL] [Abstract][Full Text] [Related]
15. FDA issues final medical device reporting regulation. Healthc Hazard Mater Manage; 1996 Feb; 9(5):5-6. PubMed ID: 10154800 [No Abstract] [Full Text] [Related]
16. FDA spells out new reporting requirements. Infante M Contemp Longterm Care; 1996 Mar; 19(3):60-1. PubMed ID: 10156261 [No Abstract] [Full Text] [Related]
17. An overview of FDA medical device regulation as it relates to deep brain stimulation devices. Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274 [TBL] [Abstract][Full Text] [Related]
18. Approving the vagus-nerve stimulator for depression. Shuchman M N Engl J Med; 2007 Apr; 356(16):1604-7. PubMed ID: 17442903 [No Abstract] [Full Text] [Related]
19. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products. Lang L Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067 [No Abstract] [Full Text] [Related]
20. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval? Barold HS Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]